Alliance Pharma (LON:APH) Stock Price Passes Below 200-Day Moving Average of $38.67

Alliance Pharma plc (LON:APH)’s stock price passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 38.67 ($0.48) and traded as low as GBX 35.50 ($0.44). Alliance Pharma shares last traded at GBX 35.50 ($0.44), with a volume of 1,069,823 shares traded.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada dropped their target price on shares of Alliance Pharma from GBX 65 ($0.80) to GBX 60 ($0.74) and set an “outperform” rating on the stock in a research report on Wednesday, January 31st.

Alliance Pharma Stock Performance

The company has a debt-to-equity ratio of 45.00, a quick ratio of 1.42 and a current ratio of 1.93. The firm’s 50 day simple moving average is GBX 39 and its 200 day simple moving average is GBX 38.67. The firm has a market capitalization of £194.54 million, a price-to-earnings ratio of -3,550.00, a PEG ratio of 1.04 and a beta of 0.60.

Alliance Pharma Company Profile

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.